Artesunate ointment

DRUG2 trials

Sponsors

Frantz Viral Therapeutics, LLC

Conditions

AINAnal HPV InfectionAnal HSILAnal High-grade Squamous Intraepithelial LesionHPV DiseaseHPV InfectionHigh Grade Intraepithelial NeoplasiaPre-Cancerous Dysplasia

Phase 2

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

RecruitingNCT06075264

Frantz Viral Therapeutics, LLCHigh Grade Intraepithelial Neoplasia, HPV Disease, HPV Infection +10

Start: 2023-12-06End: 2027-12-31Target: 27Updated: 2025-08-14

Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants

RecruitingNCT06206564

Frantz Viral Therapeutics, LLCAIN, Anal High-grade Squamous Intraepithelial Lesion, Anal HPV Infection +1

Start: 2024-01-12End: 2026-12-31Target: 48Updated: 2025-05-18

Related Papers

Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial

Cancer Control2025-08-01